FDA approves new pancreatic cancer drug
(HealthDay)—The U.S. Food and Drug Administration has approved a new drug called Onivyde as part of a treatment regimen for advanced pancreatic cancer.
Oct 22, 2015
0
14
(HealthDay)—The U.S. Food and Drug Administration has approved a new drug called Onivyde as part of a treatment regimen for advanced pancreatic cancer.
Oct 22, 2015
0
14
Research with human tissue and cells suggests that genetic variations, in addition to failure to comply with treatment regimens, may account for some failures of an anti-HIV drug to treat and prevent HIV infection.
Jul 9, 2015
0
11
How most babies are protected from acquiring HIV from their infected mothers has been a matter of scientific controversy. Now researchers at Duke Medicine provide new data identifying an antibody response that had long been ...
Jun 8, 2015
0
22
Since HIV emerged in the '80s, drug "cocktails" transformed the deadly disease into a manageable one. But the virus is adept at developing resistance to drugs, and treatment regimens require tweaking that can be costly. Now ...
Mar 18, 2015
0
53
Patients with muscle-invasive bladder cancer often benefit from chemotherapy before surgery to remove the tumor, but a test of one regimen by researchers at Fox Chase Cancer Center was halted when too many people experienced ...
May 30, 2014
0
0
Adults with low-grade gliomas, a form of brain tumor, who received a chemotherapy regimen following completion of radiation therapy, lived longer than patients who received radiation therapy alone, according to long-term ...
Feb 4, 2014
0
0
Patients better adhered to their medication regimens in the year following hospitalization for acute coronary syndrome (ACS) when they were part of a program that included personalized attention from a pharmacist compared ...
Nov 18, 2013
0
0
Treatment with two common drugs reduced viral replication and lung damage when given to monkeys infected with the virus that causes Middle East Respiratory Syndrome. The condition is deadly pneumonia that has killed more ...
Sep 8, 2013
0
0
In a study of an all-oral drug regimen, a majority of volunteers with liver damage due to hepatitis C virus (HCV) infection were cured following a six-month course of therapy that combined an experimental drug, sofosbuvir, ...
Aug 27, 2013
0
0
(HealthDay)—The addition of tofacitinib to rheumatoid arthritis (RA) treatment regimens improves patient response to non-biologic disease-modifying antirheumatic drugs (DMARDs), according to a study published in the Aug. ...
Aug 22, 2013
0
0